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Abstract
Background: Pulmonary rehabilitation (PR), delivered as a supervised multidisciplinary program including exercise
training, is one of the cornerstones in the chronic obstructive pulmonary disease (COPD) management. We performed a
systematic review and meta-analysis to assess the effect on mortality of a supervised early PR program, initiated during
or within 4 weeks after hospitalization with an acute exacerbation of COPD compared with usual post-exacerbation care
or no PR program. Secondary outcomes were days in hospital, COPD related readmissions, health-related quality of life
(HRQoL), exercise capacity (walking distance), activities of daily living (ADL), fall risk and drop-out rate.
Methods: We identified randomized trials through a systematic search using MEDLINE, EMBASE and Cocharne Library
and other sources through October 2017. Risk of bias was assessed regarding randomization, allocation sequence
concealment, blinding, incomplete outcome data, selective outcome reporting, and other biases using the Cochrane
Risk of Bias tool.
Results: We included 13 randomized trials (801 participants). Our meta-analyses showed a clinically relevant reduction
in mortality after early PR (4 trials, 319 patients; RR = 0.58 (95% CI: [0.35 to 0.98])) and at the longest follow-up (3 trials,
127 patients; RR = 0.55 (95% CI: [0.12 to 2.57])). Early PR reduced number of days in hospital by 4.27 days (1 trial, 180
patients; 95% CI: [− 6.85 to − 1.69]) and hospital readmissions (6 trials, 319 patients; RR = 0.47 (95% CI: [0.29 to 0.75])).
Moreover, early PR improved HRQoL and walking distance, and did not affect drop-out rate. Several of the trials had
unclear risk of bias in regard to the randomization and blinding, for some outcome there was also a lack of power.
Conclusion: Moderate quality of evidence showed reductions in mortality, number of days in hospital and number of
readmissions after early PR in patients hospitalized with a COPD exacerbation. Long-term effects on mortality were not
statistically significant, but improvements in HRQoL and exercise capacity appeared to be maintained for at
least 12 months. Therefore, we recommend early supervised PR to patients with COPD-related exacerbations.
PR should be initiated during hospital admission or within 4 weeks after hospital discharge.
Keywords: Chronic obstructive pulmonary disease, Supervised early pulmonary rehabilitation, Exacerbation of
COPD, Hospital readmissions, Mortality, Systematic review
* Correspondence: camilla.koch.ryrsoe@regionh.dk; http://www.inflammation-
metabolism.dk; http://aktivsundhed.dk
1The Centre of Inflammation and Metabolism and the Centre for Physical
Activity Research, Rigshospitalet, University of Copenhagen, Blegdamsvej 9,
DK-2100 Copenhagen, Denmark
2Danish Health Authority, Copenhagen, Denmark
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Ryrsø et al. BMC Pulmonary Medicine  (2018) 18:154 
https://doi.org/10.1186/s12890-018-0718-1
Background
Acute exacerbation in chronic obstructive pulmonary dis-
ease (AECOPD) is the most common reason for hospital
admission among patients with chronic obstructive pul-
monary disease (COPD) [1]. These events result in higher
mortality and lower quality of life [2]. The estimated mor-
tality rate within 90 days after hospitalization for AECOPD
is approximately 3.6% (1.8–20.4%) while mortality rate dur-
ing the first 2 years after admission for AECOPD is
approximately 31.0% (18.8–45.4%) [3]. The estimated
30-day and 12-month readmission-rate after AECOPD
hospitalization is approximately 19.2% [4] and 42.3% [5], re-
spectively. Readmission following an AECOPD has a nega-
tive effect on physical performance by lowering exercise
capacity, muscle strength and physical activity level, which
patients may never fully recover from [6, 7]. Patients with
frequent exacerbations may be prone to a more rapid
decline in activities of daily living (ADL) and functional
capacity, which is associated with reductions health-related
quality of life (HRQoL) [6]. Repeated exacerbations may
cause a vicious circle as physical inactivity and low exercise
capacity are related to a higher risk of hospital readmission,
regardless of the COPD severity [8].
Pulmonary rehabilitation (PR) has been suggested in
AECOPD because of its known beneficial effects on
exercise capacity, HRQoL and symptom burden in stable
patients [9, 10]. It should be noted that the evidence in
favor of PR in stable COPD is based on studies investi-
gating supervised PR programs including exercise train-
ing for 6–12 weeks [11, 12], although at long-term
follow-up, adherence to exercise training is low and
effects are not maintained [13]. Likewise, studies have
shown that early PR, initiated at the beginning of exacer-
bation treatment or within 3 weeks of initiation of
exacerbation treatment, improves exercise capacity and
HRQoL along with reductions in hospital readmissions
[14] and mortality [15] compared with no PR. Based on
evidence from randomized controlled trials (RCT), NICE
guidelines from 2011 recommended the use of early PR
in patients hospitalized with COPD exacerbations [16].
Yet, recent concerns have been raised about PR not be-
ing safe in AECOPD when initiated during the hospital
admission [17]. Based on this new evidence, the 2017
guideline from the European Respiratory Society (ERS)
and American Thoracic Society (ATS) recommend that
PR is not initiated during hospitalization in patients with
COPD related exacerbations, but is delayed until after
hospital discharge (within 3 weeks) [18]. However, the
ERS/ATS recommendation was based on both super-
vised and unsupervised PR programs, and interestingly,
the potentially negative effects of early PR were mainly
driven by studies providing unsupervised PR.
Therefore, our aim was to investigate the effect of a
supervised early PR program, initiated during or within
4 weeks, in patients hospitalized with a COPD exacerba-
tion compared with usual care. Our primary outcome
was mortality at the end of PR and at the longest
follow-up. Secondary outcomes were hospital readmis-
sion, days in hospital, HRQoL and exercise capacity. We
followed the guidelines of the Grading of Recommenda-
tions Assessment, Development and Evaluation (GRADE)
Working Group [19] in order to support clinical decision
making in a national Danish setting where only supervised
PR programs take place.
Methods
Protocol and registration
This review was among a series of reviews performed for
a guideline developed by the Danish Health Authority.
The population, intervention, control intervention (com-
parison) as well as critical and important outcomes
(PICO) [20] were determined by the working-group mem-
bers prior to our literature search. The methods and
review process are a standardized part of the guideline
development process within the Danish Health Authority.
The methods handbook (in Danish) as well as the full
guideline and more detail regarding the PICO can be
accessed at www.sst.dk, the full guideline can also be
found on https://app.magicapp.org/app#/guideline/2551.
Eligibility criteria
We considered studies eligible if they compared the ef-
fect of early supervised PR initiated during admission or
within 4 weeks of hospital discharge (intervention) with
no early pulmonary rehabilitation/usual care (compari-
son) in patients admitted and/or having been admitted
to hospital with exacerbations of COPD (population).
The PR was defined by a main component of supervised
exercise training but could contain education, smoking
cessation, nutritional support, management in activities
of daily living (ADL) and physio-social support.
Studies providing inpatient pulmonary rehabilitation
with exercise training was included if rehabilitation were
continued after hospital discharge and/or a comprehen-
sive rehabilitation program could be documented. Studies
were excluded if they were not randomized or did not
cover the predefined PICO. Our pre-specified outcomes
were evaluated immediately after the end of intervention
and at the longest follow up. Our primary outcome was
mortality while secondary outcomes included number of
days in hospital, number of COPD related hospital read-
missions, health related quality of life (HRQoL), exercise
capacity (walking tests), activities of daily living (ADL),
falls and dropout.
Information sources and search strategy
A research librarian and search specialist performed the sys-
tematic literature search including the following databases:
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Medline, Embase, Physiotherapy Evidence Database (PE-
DRO), CINAHL, G-I-N international, NICE, National
Guideline Clearinghouse, Surgical Implant Generation
Network, Cochrane Library and OTseeker. The full search
strategy is presented in Additional file 1.
This review is an update of a previous review. First, a
comprehensive search for COPD rehabilitation guide-
lines and systematic reviews was conducted in July
2013, yielding a total of 2412 records. In November
2013, a second and more specific search (Medline,
Embase and PEDRO) for RCTs was performed, in
which 876 additional records were identified. An up-
dated search for guidelines and systematic reviews was
conducted in July 2017, covering the period from July
2013 to July 2017, where we identified 460 additional
records. The search for primary studies was updated in
October 2017, covering the period from December
2013 to October 2017. The search resulted in 1187 add-
itional records (Fig. 1). All records were screened for
relevant titles or abstracts, while reference lists of
included studies were assessed for further eligible
literature.
Study selection
Clinical guidelines identified in the first search were
evaluated with the Appraisal of Guidelines for Research
and Evaluation instrument version II (AGREE II) by two
independent authors and disagreement was resolved
through consensus (see Additional file 2). Likewise, sys-
tematic reviews were assessed with A Measurement
Tool to Asses Systematic Reviews (AMSTAR) by three
authors and disagreement was resolved through consen-
sus (see Additional file 3). Based on these assessments
we decided to include one clinical guideline [21] and
two systematic reviews [14, 15]. From the second search,
two authors independently evaluated the full text of all
potentially eligible studies and decided whether to in-
clude or exclude each study based on the prespecified
criteria.
Data analysis and risk of bias
Data on participants, study design, interventions and out-
comes were extracted from the full-text reports of the in-
cluded studies by two independent authors, using
Covidence (Covidence systematic review software, Veritas
Fig. 1 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram of the article selection processes
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Health Innovation, Melbourne, Australia. Available at
www.covidence.org). Disagreement was resolved through
consensus. Each included study was assessed using the
Cochrane risk of bias tool [22]. Two independent authors
performed the risk of bias assessment, and disagree-
ment was resolved through discussion and consensus
(see Additional file 4).
We used mean difference (MD) to calculate effect esti-
mates for continuous outcomes if the same scale was
used for a particular outcome. When pooling continuous
outcome data from different scales a standardized mean
difference (SMD) was calculated. Rate ratio and relative
risk (RR) was used to calculate effects for dichotomous
outcomes. Random-effects meta-analyses were performed
as we expected variation in population, duration of inter-
vention, and types of training between the included stud-
ies. Review Manager 5.3 software [23] was used for the
statistical analyses and to produce forest plots. Heterogen-
eity in the effect estimate was determined using the
I-square (I2) statistic and values below 40% indicated low
heterogeneity [24].
The quality of evidence for each outcome was assessed
across the included studies as proposed by the GRADE
Working Group [25]. A draft of the grading for each out-
come using the GRADE criteria (i.e., risk of bias, inconsist-
ency, indirectness, imprecision, and publication bias) was
presented to the working group and the final grading was
reached through discussion and consensus. The full guide-
line was then submitted to peer review and public hearing.
For details on the hearing see www.sst.dk (in Danish).
Assessment of PR extensiveness
We assessed the extensiveness of the PR program in the
included trials by following the statements and guide-
lines from BTS [26], ERS/ATS [10]), and as described in
Puhan et al. [14] (see Additional file 5).
Results
Study selection
We identified 13 eligible primary RCTs for our analysis.
These included a total of 801 participants who were in the
recovery phase of a recent COPD exacerbation. Excluding
dropouts (167 participants), 634 participants were included
in our analysis. Nine of the 13 studies were included in a
systematic Cochrane review [14]. Figure 1 summarizes the
flow diagram of the two selection processes.
Included studies
Table 1 shows the characteristics of the included studies.
In three studies [27–29] patients initiated an inpatient
PR program within 4 to 8 days of hospital admission. In
one study [30] patients began PR as either in- or outpa-
tients and all continued as outpatients, in eight studies
[31–38] the outpatient program was initiated within
one to four weeks after the inpatient exacerbation treat-
ment and in one study [39] the outpatient rehabilitation
was initiated after the “hospital at home” treatment of
the exacerbation. In four studies [27, 29, 38, 39] the PR
consisted of only supervised exercise training, whereas
in the remaining nine studies [28, 30–37] PR consisted
of supervised exercise training and education, smoking
cessation, nutritional support, management in activities
of daily living (ADL) and physio-social support. Duration
of the different PR programs was ten days to six months,
with training frequencies ranging from two to seven
times a week, and exercise durations of 30–90 min per
session. Table S1 in the Additional file 5 shows the
extensiveness of the PR programs in the included trials.
The participants followed an extensive PR program in
ten of the included trials [27–31, 33–36, 38]. In the
remaining three studies, the extensiveness of the PR was
deemed as moderate [39], slightly extensive [37], and
undescribed [32]. The control group received usual care
consisting of optimal medical treatment. There were no
reported differences in baseline characteristics of pa-
tients between groups in all of the included studies.
Risk of bias within studies
Figures 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 and Additional
file 4 shows risk of bias of the included studies. In nine
studies [28, 29, 31, 32, 34–38] the allocation conceal-
ment was not described, while seven studies [27, 29, 31,
36–39] did not report the randomization process. Three
studies [27, 34, 39] blinded the personnel, with only two
of the studies [34, 39] blinding the outcome assessor.
One study [27] was assessed as having a high risk of in-
complete outcome data reporting due to a large dropout.
Selective outcome reporting of outcome measures was
detected in one study [34]. No other sources of bias
were detected. Thus, the quality of evidence from all
studies included was downgraded due to risk of bias
(Table 2, Additional file 4).
Effect of the intervention
We preformed meta-analyses in ten of our predefined
outcomes. Subgroup analyses were undertaken in order
to reveal differences between PR initiated during admis-
sion or within one week after discharge and PR initiated
between one and four weeks after discharge from hos-
pital. For an overview of all the outcomes, our confi-
dence in the estimates and our interpretations see Table
2 GRADE Evidence profile.
Mortality
Total mortality after end of treatment was reported in
four of the included studies, including 319 randomized
participants (early PR: N = 163; usual care: N = 156) [29,
32, 33, 37]. A total of 18 events were reported in the
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early PR group, whereas 27 events were reported in
the usual care group. We found a statistically signifi-
cant reduction in mortality favoring PR (RR = 0.58
(95% CI: [0.35 to 0.98])), with low heterogeneity
(Fig. 2). The quality of evidence was downgraded due
to unclear sequence generation, allocation conceal-
ment and blinding together with selective outcome
reporting (Table 2).
Total mortality at longest follow up was reported in
three of the included studies, including 127 partici-
pants (early PR: N = 64; usual care: N = 63) [26, 33,
34]. Two events were reported in the early PR groups
while four events were reported in the usual care
group. We found no statistical significant difference
between groups (RR = 0.55 (95% CI: [0.12 to 2.57])).
Subgroup analysis showed no difference in effect be-
tween trials with PR initiated during admission and
after discharge (P = 0.70) (Fig. 3). Our confidence in
the effect estimate was downgraded due to unclear
sequence generation and allocation concealment to-
gether with lack of precision, incomplete outcome
data and selective reporting (Table 2).
Fig. 2 The effect of supervised early PR versus usual care on mortality at the end of treatment.
Fig. 3 The effect of supervised early PR versus usual care on mortality at the longest follow up
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Days in hospital
One study investigated the effect of early PR on the num-
ber of days in hospital after the end of treatment and
stated that early PR led to a statistically reduction of
4.27 days (95% CI: [− 6.85 to − 1.69]) in the number of
days in hospitals (Fig. 4). Accordingly, our confidence in
the effect estimate was downgraded due to inclusion of
only one study (Table 2).
COPD related hospital readmissions
Six studies provided data from 365 participants on the num-
ber of COPD related hospital readmissions 3–12 months
from baseline [27, 28, 33, 35, 36, 38]. The pooled effect
estimate showed a decrease in the number of COPD related
hospital readmissions favoring the early PR (RR = 0.47 (95%
CI: [0.29 to 0.75])). Low heterogeneity (I2 = 38%) was ob-
served, and the subgroup analysis showed no difference in
effect between trials with PR initiated during admission and
after discharge (P = 0.93) (Fig. 5). The quality of evidence
was downgraded due to unclear sequence generation and
allocation concealment together with lack of blinding and
incomplete outcome date (Table 2).
Health-related quality of life
The St. George’s Respiratory Questionnaire (SGRQ)
(scale from 0 to 100, lower is better) were used across
Fig. 4 The effect of supervised early PR versus usual care on days in hospital at the end of treatment
Fig. 5 The effect of supervised early PR versus usual care on COPD related hospital readmissions at the longest follow up
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studies to assess HRQoL. Two studies were included
and data from 86 participants were pooled in a meta-
analysis evaluating HRQoL directly after end of early PR
[31, 32] and showed a statistically and clinically signifi-
cant improvement of 19.43 units on the SGRQ scale
(95% CI: [− 29.09 to − 9.77]) in the early PR group
compared with the usual care group (Fig. 6) with low
heterogeneity. Our confidence in the effect estimate was
downgraded due to unclear sequence generation, alloca-
tion concealment, blinding of assessors and incomplete
outcome data (Table 2).
Four different studies provided data from 323 partici-
pants on the effect of early PR on HRQoL 3–12 months
from baseline [33–36] and showed a statistically and
clinically relevant improvement of 8.74 units on the
SGRQ scale (95% CI: [− 12.02 to − 5.45]) in the early PR
group compared with the usual care group (Fig. 7). Sub-
group analysis showed no difference in effect between
trials with PR initiated during admission and after
discharge (P = 0.49). Unclear sequence generation, allo-
cation concealment, blinding and selective outcome
reporting led to downgrading of the confidence in our
effect estimates (Table 2).
Walking distance
The walking distance (6-Minute Walking Test (6MWT)
or Shuttle Walking Test (SWT)) after the end of treat-
ment was investigated in eight studies [28, 29, 31, 32,
36–39]. Pooling the results (early PR: N = 139; usual
care: N = 135) from five trials using 6MWT yielded a
statistically significant mean difference in walking dis-
tance of 76.89 m, favoring early PR (95% CI: [21.34 to
Fig. 6 The effect of supervised early PR versus usual care on health-related quality of life at the end of treatment using the St. George’s
Respiratory Questionnaire
Fig. 7 The effect of supervised early PR versus usual care on health-related quality of life at the longest follow up using the St. George’s
Respiratory Questionnaire
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132.45]) with high heterogeneity (Fig. 8). The subgroup
analysis showed no difference in the effect between PR
initiated during admission and after discharge (P = 1.00).
However, we found a significant within-group effect of
early PR after discharge (Fig. 8). The quality of evidence
was downgraded due to unclear sequence generation, al-
location concealment, blinding of assessors and incomplete
data together with high risk of inconsistency (Table 2).
Three trials (early PR: N = 50; usual care: N = 45) used the
SWT to evaluate the walking distance after the end of treat-
ment and showed a statistically significant mean difference
in walking distance of 54.70 m, favoring early PR (95% CI:
[30.83 to 78.57]). The subgroup analysis showed no differ-
ence in the effect between PR initiated during admission
and after discharge (P = 0.40). However, we found a signifi-
cant within-group effect of early PR during admission and
after discharge (Fig. 9). The quality of evidence was down-
graded due to unclear sequence generation, allocation
Fig. 8 The effect of supervised early PR versus usual care on walking distance at the end of treatment using the 6-Minute Walking Test
Fig. 9 The effect of supervised early PR versus usual care on walking distance at the end of treatment using the Shuttle Walking Test
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concealment, blinding of assessors, incomplete outcome to-
gether with selective outcome reporting (Table 2).
Three different studies provided data from 217 partici-
pants on the effect of early PR on walking distance
assessed by 6MWT at 3–12 months from baseline [27, 33,
34] and showed no statistically, but a clinically relevant
difference (mean difference: 90.27 m; 95% CI: [− 69.53 to
250.08]) with high heterogeneity (Fig. 10). Subgroup ana-
lysis showed a statistically significant difference between
groups in favor of early PR during admission (P < 0.01)
(Fig. 10). Due to unclear sequence generation, allocation
concealment, blinding of assessors, incomplete data and
Fig. 10 The effect of supervised early PR versus usual care on walking distance at the longest follow up using the 6-Minute Walking Test
Fig. 11 The effect of supervised early PR versus usual care on dropout at the end of treatment
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selective reporting together with high risk of inconsistency
leading to high risk of imprecision the quality of evidence
was downgraded (Table 2).
Drop-outs
The effect of early PR on the drop-out rate at the
end of treatment was investigated in eight studies
providing data from 440 randomized participants
(early PR: N = 228; usual care: N = 212) [27, 28, 30,
34, 35, 37–39]. A total of 54 drop-outs were reported
in the early PR group, whereas 46 drop-outs were re-
ported in the usual care group, with no significant
difference between groups (RR = 0.99 (95% CI: [0.71
to 1.39])) (Fig. 11). The subgroup analysis showed no
difference in the effect between PR initiated during
admission and after discharge (P = 0.37). Our confi-
dence in the effect estimate was downgraded due to
unclear sequence generation, allocation concealment,
blinding of assessors and incomplete data outcome
together with high risk of inconsistency (Table 2).
Three different studies provided data from 181 partici-
pants on the effect of early PR on drop-out at 3–
18 months from baseline (early PR: N = 92; usual care:
N = 89) [34, 36, 38]. A total of 20 drop-outs were re-
ported in the early PR group, while 18 drop-outs were
reported in the usual care group, with no difference be-
tween groups (RR = 1.05 (95% CI: [0.60 to 1.85])) (Fig. 12,
Table 2). Subgroup analysis showed no difference in the
effect between trials with PR initiated during admission
and after discharge (P = 0.30; I2 = 6.5%) (Fig. 12).
None of the included studies reported results on the
effect of early PR on ADL or the risk of falling.
Discussion
Summary of main findings
The present review summarized the evidence from 13
RCTs including 634 participants with an exacerbation of
COPD and compared the use of early PR (N = 322) with
usual care (N = 312). Subsequent meta-analysis showed
that supervised early PR after acute exacerbation of
COPD reduced mortality and number of days in hospital
together with a reduction in COPD related hospital ad-
missions and an improvement of HRQoL and exercise
capacity (walking distance).
Mortality
We found that supervised early PR in patients with ex-
acerbation of COPD reduced risk of mortality by ~ 42%
compared with usual care. This finding was based on
moderate quality of evidence due to methodological is-
sues in the included studies and the relatively small
numbers of participants. While similar conclusions have
been reported in guidelines and systematic reviews in
the past, results from a resent RCT by Greening et al.
questioned the beneficial effects by reporting higher
mortality in the early PR group [15–17]. In this study
authors included patients with COPD related exacerba-
tions during admission and instructed participants in the
intervention group to be more physical active the next
three months facilitated by technical devices [17]. In
contrast, the majority of evidence favoring PR in stable
Fig. 12 The effect of supervised early PR versus usual care on dropout at the longest follow up
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Table 2 GRADE Evidence Profile
Supervised early PR versus usual care for patients with acute exacerbation of COPD
Outcome Timeframe Study results and
measurements
Absolute effect
estimates
Certainty in the effects
estimates (Quality of evidence)
Plain text summary
Usual
care
Early
PR
Mortality
End of treatment
Critical
Relative risk 0.58
(CI 95% 0.35–0.98)
Based on data from 319
patients (4 studies)
173
per
1.000
100
per
1.000
Moderate
Due to serious risk of biasa
Early pulmonary rehabilitation probably
decreases mortality at the end of treatment
Difference: 73
fewer per 1.000
(CI 95% 112
fewer - 3
fewer)
Mortality
Longest follow-up
Critical
Relative risk 0.55
(CI 95% 0.12–2.57)
Based on data from 127
patients (3 studies)
63
per
1.000
35
per
1.000
Low
Due to serious risk of bias
and serious risk of imprecisiona,b
Early pulmonary rehabilitation may decrease
mortality slightly at the longest follow-up
Difference: 28
fewer per 1.000
(CI 95% 55
fewer - 99
more)
Days in hospital
End of treatment
Important
Measured by: Days
Lower is better
Based on data from 180
patients (1 study)
0.86
(mean)
4.59
(mean)
Moderate
Due to serious imprecisionc
Early pulmonary rehabilitation probably
decreases days in hospital at the end
of treatment
Difference: MD
4.27 lower
(CI 95% 6.85
lower - 1.69
lower)
Days in hospital
Longest follow-up
Important
No studies were found that looked at
number of days in hospital at the
longest follow-up
Readmission due to
exacerbation
End of treatment
Important
No studies were found that looked at
readmission to hospital due to
exacerbation at the end of treatment
Readmission due to
exacerbation
Longest follow-up
Important
Rate ratio 0.47
(CI 95% 0.29–0.75)
Based on data from 365
patients (6 studies)
Moderate
Due to serious risk of biasa,d
Early pulmonary rehabilitation probably
decreases readmission to hospital due to
exacerbation at the longest follow-up
Health-related quality
of life
End of treatment
Important
Measured by: SGRQ
Lower is better
Based on data from 86
patients (2 studies)
Difference: MD
19.43 lower
(CI 95% 29.09
lower - 9.77
lower)
Low
Due to serious risk of bias and
serious risk of imprecisiona,c
Early pulmonary rehabilitation may improve
health-related quality of life at the end
of treatment
Health-related quality
of life
Longest follow-up
Important
Measured by: SGRQ
Lower is better
Based on data from 323
patients (4 studies)
Difference: MD
8.74 lower
(CI 95% 12.02
lower - 5.45
lower)
Moderate
Due to serious risk of biasa,d
Early pulmonary rehabilitation probably
improves health-related quality of life at
the longest follow-up
Exercise capacity
End of treatment
Important
Measured by: SWT (meters)
Higher is better
Based on data from 95
patients (3 studies)
Difference: MD
54.7 more
(CI 95% 30.83
more - 78.57
more)
Moderate
Due to serious risk of biasa,d
Early pulmonary rehabilitation probably
increases exercise capacity at the end
of treatment
Exercise capacity
End of treatment
Important
Measured by: 6MWT
(meters)
Higher is better
Based on data from 274
patients (5 studies
Difference: MD
76.89 more
(CI 95% 21.34
more - 132.45
more)
Low
Due to serious risk of bias
and serious inconsistencya,d,e
Early pulmonary rehabilitation probably
increases exercise capacity at the end
of treatment
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COPD is based on supervised programs, and therefore
we did not include Greening et al. in our review. How-
ever, to assess safety of early PR initiated during the hos-
pital admission we performed a subgroup analysis
showing no difference between groups rehabilitated dur-
ing the admission and after discharge.
Results from this review differ from a previous review
by Puhan et al. [14] who showed no statistically signifi-
cant effect of early PR on mortality, but when the au-
thors preformed a subgroup analysis, excluding results
from Greening et al. [17], they did find a positive effect
of early PR on mortality [14]. Moreover, the review by
Puhan et al. [14] differs methodologically from the
present review, as they included any inpatient and/or
outpatient PR program with no criteria for the compre-
hensiveness or supervision of the rehabilitation program.
We only included studies of supervised PR programs
similar to what is offered to COPD patients in Denmark,
which is based on the present large amount of evidence
in favor of supervised PR in stable COPD. This might
explain the lower heterogeneity and greater effects on
mortality in the present review.
Table 2 GRADE Evidence Profile (Continued)
Supervised early PR versus usual care for patients with acute exacerbation of COPD
Outcome Timeframe Study results and
measurements
Absolute effect
estimates
Certainty in the effects
estimates (Quality of evidence)
Plain text summary
Usual
care
Early
PR
Exercise capacity
Longest follow-up
Important
Measured by: SWT (meters)
Higher is better
Based on data from 2017
patients (3 studies)
Difference: MD
90.27 higher
(CI 95% 69.53
lower - 250.08
higher)
Low
Due to serious risk of bias and
serious inconsistency leading
to serious imprecisiona,b,d,e
Early pulmonary rehabilitation may
increase exercise capacity at the
longest follow-up
Dropout rate
End of treatment
Important
Relative risk 0.99
(CI 95% 0.71–1.39)
Based on data from 440
patients (8 studies)
217
per
1.000
215
per
1.000
Moderate
Due to serious risk of biasa,d
Early pulmonary rehabilitation
probably has little impact on
the dropout rate at the end
of treatment
Difference: 2
fewer per 1.000
(CI 95% 63
fewer - 85
more)
Dropout rate
Longest follow-up
Important
Relative risk 1.05
(CI 95% 0.6–1.85)
Based on data from 181
patients (3 studies)
202
per
1.000
212
per
1.000
Moderate
Due to serious risk of biasa,d
Early pulmonary rehabilitation
probably has little impact on
dropout at the longest
follow-up
Difference: 10
more per 1.000
(CI 95% 81
fewer - 172
more)
Falls
Longest follow-up
Important
No studies were found that looked at
falls at the longest follow-up
Activities of daily
living
End of treatment
Important
No studies were found that looked
at activities of daily living at the
end of treatment
Activities of daily
living
Longest-follow-up
Important
No studies were found that looked at
activities of daily living at the longest
follow-up
CI confidence interval, COPD chronic obstructive pulmonary disease, MD middle difference, PR pulmonary rehabilitation, SGRQ St. George’s Respiratory
Questionnaire, SWT Shuttle Walking Test, 6MWT 6 min walking test
Quality of evidence. High quality: We are very confident that the true effect lies close to that of the estimate of the effect; Moderate quality: We are moderately
confident in the effect estimate, the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different; Low
quality: Our confidence in the effect estimate is limited, the true effect may be substantially different from the estimate of the effect
aRisk of bias: Serious. Unclear/inadequate sequence generation and unclear/inadequate concealment of allocation during randomization process resulting in
potential for selection bias
bRisk of imprecision: Serious. Wide confidence intervals
cRisk of imprecision: Serious. Low number of patients
dRisk of bias: Serious. Inadequate/unclear or lack of blinding of outcome assessors resulting in potential for detection bias
eRisk of inconsistency: Serious. The magnitude of statistical heterogeneity was high
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Hospital length of stay and readmissions
Moderate-quality evidence showed that supervised early
PR significantly reduced the risk of COPD related hos-
pital readmissions at the longest follow up with 53%. In
addition, the number of days in hospital was reduced by
an average of 4.27 days. Puhan et al. [14] have previously
shown that PR significantly reduced the mean number
of hospital admissions per participant from 1.6 to 0.9
during the year following after hospital admission for an
acute exacerbation. Several explanations have been pro-
posed for the substantial effect of PR on hospital readmis-
sion. The main reason is probably that hospitalization
following an acute exacerbation of COPD leads to signifi-
cant reductions in activity level [6]. It is well known that
the recovery period after an acute exacerbation is long,
even for patients with no subsequent exacerbations [40].
Thus, PR can be considered an effective intervention for
reverting physical inactivity [41] and it has been shown that
patients who achieved improvement in their daily physical
activity level after an exacerbation of COPD experienced a
~ 50% reduction in risk of hospital readmission [42].
Health-related quality of life and exercise capacity
The primary result to support this, in the present review,
are clinically relevant improvements in walking distance
of respectively 76.89 m in 6 min walking distance
(6MWD) and 54.70 m in shuttle walking distance (SWD)
immediately after early PR and an improvement of
90.27 m in 6MWD at the longest follow up [43], which
are in line with those results from Puhan et al. [14], show-
ing an improvement of 62.38 m in 6MWD after early PR.
Secondly, we found moderate quality of evidence support-
ing a clinically important improvement in HRQoL imme-
diately after participation of 19.43 units on the SGRQ
scale and an improvement of 8.74 units at the longest fol-
low up. These effects on HRQoL exceeded the minimal
clinically important difference (MCID) for the SGRQ (>
4-point improvement [44]), and the results are in line with
previous studies showing a large effect of PR on HRQoL
in stable patients with COPD [14]. Although statistically
non-significant, the beneficial effects of early PR versus
usual care on SGRQ at the longest follow up (8.74 units)
in present review were close to those observed in stable
COPD patients (6.89 units) [9]. In addition, the present re-
view found a greater improvement in HRQoL at the end
of treatment in patients with an exacerbation of COPD
compared with stable COPD patients, which probably is
due to the lower baseline during recovery from AECOPD.
Clinical application
We found no difference in drop-out rate between partic-
ipants allocated to early PR compared with usual care.
Thus, the effects were not driven solely by positive
responders to PR, and secondly, the most severely
affected patients will likely complete or drop-out to the
same extent as usual care. As before mentioned, we did
not include Greening et al. [17], since this study has
been highly criticized for not offering a sufficiently ex-
tensive PR programs [45, 46], and interestingly, authors
reported a high number of drop-outs. The participants
in the rehabilitation group attended an average of 2.6 su-
pervised sessions during hospital admission, followed by
mainly unsupervised training after discharge, with a poor
adherence to the home self-management exercise pro-
gram (mean of 57.5) [17]. Nevertheless, these results
suggest that it is important to assess how the PR is deliv-
ered. PR programs can differ in many aspects, which may
influence their effectiveness. When assessing the extensive-
ness of the PR program; the number of exercise training
sessions, frequency of exercise training, type of exercise
training and supervision of training, as well as
self-management, education and adherence to the PR pro-
gram need to be considered [26].
In this review ten studies implemented an extensive PR
program which mostly showed large and consistent effects
on mortality, days in hospital, COPD related hospital
readmissions, HRQoL, and walking distance. The PR pro-
grams were not exactly similar within the reviewed stud-
ies, but the majority provided either many training
sessions (more than 16 sessions) [27, 29–31, 33, 34, 38],
programs of long duration (> 12 weeks) [27, 38], or sup-
ported education [28, 30, 33, 35, 36]. Nevertheless, our
results show that supervised early PR programs across
studies with different protocols are effective in patients
with COPD-related exacerbations.
Safety
Currently, the ideal timing of the onset of PR after
AECOPD is highly debated. Based on low-quality of evi-
dence, the ERS/ATS Task Force made a conditional
recommendation against the initiation of PR during
hospitalization since PR initiated during admission was
found to increase mortality [18]. This conclusion seems
based solely on results from Greening et al. [17], who re-
ported a higher mortality in the unsupervised home-based
rehabilitation group at 12 months compared with usual
care group. The difference between groups however, was
not related to the early rehabilitation intervention. Indeed,
the per protocol analysis did not show a difference in mor-
tality [17], suggesting that the participants who actually re-
ceived the intervention were not accountable for the
increased mortality [47]. We did not find any harms of
early supervised PR across 13 RCTs, even when we iso-
lated the subgroup that initiated PR during admission.
Conclusion
The results of the present review support the substantial
and clinical important benefits of supervised early PR,
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indicating that this is an effective intervention with the
purpose of reducing mortality following a hospitalization
for AECOPD. Our meta-analysis shows that supervised
PR during the recovery period after an AECOPD is su-
perior to usual care in terms of improving prognosis,
HRQoL and walking distance. Based on moderate to low
quality of evidence, we conclude that supervised early
PR reduces the risk of mortality, COPD-related hospital
readmissions and the number of days in hospital, and
lead to large and clinically relevant improvements in
HRQoL and walking distance. Therefore, we recommend
supervised PR to patients with COPD-related exacerba-
tions. PR should be initiated during hospital admission
or within 4 weeks after hospital discharge.
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